Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may represent a novel potential pharmacotherapeutic tool for alcohol use disorder (AUD).
- Growing evidence indicates a possible link between GLP-1RAs and reduced alcohol consumption.
- The study aims to explore how GLP-1RA prescriptions correlate with alcohol use in individuals diagnosed with AUD.
- If confirmed, this association could provide new insights into treatment options for AUD.
Simplified